Table 2 Baseline Demographics of patients with COVID-19.
From: Prognostic value of cardiac biomarkers in COVID-19 infection
Author | AGE (median) | Male gender, n (%) | Hypertension, n (%) | Diabetes, n (%) | Cardiovascular disease, n (%) | COPD, n (%) |
|---|---|---|---|---|---|---|
Ruan et al.22 | 57.7 | 102/150 (68) | 53/150 (35) | 26/150 (17) | 14/150 (9) | 3/150 (2) |
Deng et al.23 | 54.1 | 124/225 (55) | 59/225 (26) | 27/225 (12) | 18/225 (8) | 25/225 (11) |
Huang et al.14 | 49 | 30/41 (73) | 6/41 (15) | 8/41 (20) | 6/41 (15) | 1/41 (2) |
Wu et al.26 | 52.4 | 128/201 (64) | 38/201 (19) | 22/201 (11) | 8/201 (4) | NR |
Wang et al.11 | 56 | 75/138 (54) | 43/138 (31) | 14/138 (10) | 21/138 (15) | 4/138 (3) |
Zhou et al.24 | 56 | 119/191 (62) | 57/191 (30) | 36/191 (19) | 15/191 (8) | 6/191 (3) |
Chen et al.25 | 62 | 171/274 (62) | 93/274 (34) | 47/274 (17) | 22/274 (8) | 19/274 (7) |
Chen et al.12 | 58.9 | 84/150 (56) | 50/150 (33) | 20/150 (13) | 9/150 (6) | NR |
Deng et al.13 | 65 | 57/112 (51) | 36/112 (32) | 19/112 (17) | 15/112 (13) | 4/112 (4) |
Guo et al.20 | 58.5 | 91/187 (49) | 62/187 (33) | 28/187 (15) | 21/187 (11) | 4/187 (2) |
Peng et al.15 | 62 | 53/112 (47) | 92/112 (82) | 24/112 (21) | 62/112 (55) | NR |
Shi et al.21 | 64 | 205/416 (49) | 129/416 (31) | 58/416 (14) | 46/416 (11) | 12/416 (3) |
Han et al.29 | 58 | 26/75 (35) | NR | NR | NR | NR |
Wang et al.28 | NR | 48/110 (44) | 23/110 (21) | 15/110 (14) | NR | 6/110 (5) |
Yan et al.26 | 69.4 | 33/48 (69) | 24/48 (50) | 48/193 (25) | 13/48 (27) | 4/48 (8) |
Zheng et al.30 | 49.4 | 51/99 (52) | NR | 2.5/41 (6) | NR | NR |
